YUHSpace

BROWSE

Export
0 199

Cited 0 times in

Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer

DC Field Value Language
dc.contributor.author정현철-
dc.date.accessioned2023-06-02T00:53:46Z-
dc.date.available2023-06-02T00:53:46Z-
dc.date.issued2022-08-
dc.identifier.issn0171-5216-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194503-
dc.description.abstractDespite new therapeutic options, advanced gastric cancer remains associated with a poor prognosis compared with other cancers. Recent gains in the treatment of gastric cancer were accompanied by the identification of novel biomarkers associated with various cellular pathways and corresponding diagnostic technologies. It is expected that the standardization of clinical workflow and technological refinements in biomarker assessment will support greater personalization and further improve treatment outcomes. In this article, we review the current state of prognostic and predictive biomarkers in gastric cancer.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish, German-
dc.publisherSpringer-Verlag-
dc.relation.isPartOfJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHB7-H1 Antigen / metabolism-
dc.subject.MESHBiomarkers, Tumor / metabolism-
dc.subject.MESHHumans-
dc.subject.MESHMicrosatellite Instability-
dc.subject.MESHPrognosis-
dc.subject.MESHStomach Neoplasms* / metabolism-
dc.titleEvolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorNicole M Myer-
dc.contributor.googleauthorKohei Shitara-
dc.contributor.googleauthorHyun C Chung-
dc.contributor.googleauthorFlorian Lordick-
dc.contributor.googleauthorRonan J Kelly-
dc.contributor.googleauthorZsolt Szabo-
dc.contributor.googleauthorZ Alexander Cao-
dc.contributor.googleauthorStephen Leong-
dc.contributor.googleauthorDavid H Ilson-
dc.contributor.googleauthorWilko Weichert-
dc.identifier.doi10.1007/s00432-021-03902-1-
dc.contributor.localIdA03773-
dc.relation.journalcodeJ01283-
dc.identifier.eissn1432-1335-
dc.identifier.pmid35551464-
dc.identifier.urlhttps://link.springer.com/article/10.1007/s00432-021-03902-1-
dc.subject.keywordBiomarkers-
dc.subject.keywordGastric cancer-
dc.subject.keywordMicrosatellite instability-
dc.subject.keywordProgrammed death ligand 1-
dc.subject.keywordTumor mutational burden-
dc.contributor.alternativeNameChung, Hyun Cheol-
dc.contributor.affiliatedAuthor정현철-
dc.citation.volume148-
dc.citation.number8-
dc.citation.startPage2023-
dc.citation.endPage2043-
dc.identifier.bibliographicCitationJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, Vol.148(8) : 2023-2043, 2022-08-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Show simple item record Find it @ YMLIB

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links